Karyopharm Therapeutics, Inc. (KPTI)
8.77
-0.05
(-0.57%)
USD |
NASDAQ |
Mar 06, 16:00
8.77
0.00 (0.00%)
After-Hours: 18:53
Karyopharm Therapeutics Free Cash Flow : -75.37M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Baxter International, Inc. | 323.00M |
| Bruker Corp. | 43.30M |
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Agios Pharmaceuticals, Inc. | -377.29M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.83M |
| Cash from Investing (Quarterly) | 5.00M |
| Cash from Financing (Quarterly) | 29.69M |
| Free Cash Flow Per Share (Quarterly) | -0.6606 |
| Free Cash Flow to Equity (Quarterly) | -49.01M |
| Free Cash Flow to Firm (Quarterly) | 0.7827M |
| Free Cash Flow Yield | -78.73% |